ProUroCare Medical Eulerpool News

ProUroCare Medical Stock News

ProUroCare Medical is being monitored by journalists and investors worldwide. We gather the latest ProUroCare Medical news here.

ProUroCare Medical Stock Press Releases

ProUroCare Medical regularly publishes news on the company's website that are relevant for investors.

ProUroCare Medical News 2026

This page contains all current news, analysis and press releases for ProUroCare Medical stock (PUMD, ISIN: US74373C2061). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at ProUroCare Medical.

ProUroCare Medical Stock

ProUroCare Medical ProUroCare Medical Inc, based in Eden Prairie, US, develops medical devices for prostate disease detection and characterization. The company focuses on the ProUroScan System, an imaging device that creates real-time elasticity images of the prostate using a rectal probe and specialized software. This system aids in visualizing abnormalities detected during digital rectal exams, offering two- and three-dimensional imaging capabilities. With a small team of two employees, ProUroCare operates in the Health Care sector, specializing in diagnostic tools for prostate health.